NOV 18, 2021 4:36 AM PST

Is Cannabis Useful for Symptoms of Endometriosis?

Endometriosis is a common gynecologic disorder impacting up to 10% of women of reproductive age in the United States. In this disease, similar tissue to the uterine lining grows in aberrant areas such as the ovaries or bowels. The disorder can cause pain, as well as infertility. Although there is currently no cure for the disease, symptoms can be managed with medication and surgery if needed. Recently, cannabis has been investigated as an agent with the potential to mitigate endometriosis-associated symptoms. 

In October 2021, the results of a retrospective cohort study including 252 participants who self-reported endometriosis were published. Participants self-reported changes in symptoms with cannabis use which included cramps, pelvic pain, gastrointestinal symptoms, and depression. Participants engaged in multiple sessions of cannabis use between April 2017 and February 2020. The method of ingestion seemed to impact treatment effectiveness with inhaled cannabis, demonstrating greater effectiveness for pain, while oral cannabis was more beneficial for mood and gastrointestinal symptoms. Although cannabis appeared effective across all symptoms investigated, gastrointestinal symptoms had the most robust self-reported improvement after cannabis use.

As this study is cross-sectional, a causal relationship between cannabis and endometriosis-associated symptoms cannot be determined. In addition, limitations exist that should be considered when reviewing the results. These limitations include the influence of potential bias due to the self-reported nature of both the diagnosis of endometriosis and symptom relief with cannabis use. Nevertheless, these findings are suggestive of a possible association between cannabis use and symptom relief. Therefore, this study supports the value of developing future clinical trials to investigate the use of cannabis for treating endometriosis-associated symptoms.

Source: Johns Hopkins Medicine, CDC, PLOS ONE

About the Author
MD
Dr. Christopher DiMaio is a Science Writer at Labroots. He received his MD from Penn State College of Medicine in 2014. His academic and professional interests include Neuroscience, Behavioral health, Immunology, and Healthcare improvement, among others. He is an active part of his community.
You May Also Like
NOV 19, 2021
Cannabis Sciences
Topical CBD Reverses UV-Induced Changes in Skin
NOV 19, 2021
Topical CBD Reverses UV-Induced Changes in Skin
Results from a new study published in Nature’s Scientific Reports suggest that topical application of cannabidiol ...
NOV 23, 2021
Infographics
The Health Benefits of Cannabis
NOV 23, 2021
The Health Benefits of Cannabis
Legislation is opening more and more doors for cannabis- causing an explosion in both research and marketing campaigns f ...
FEB 03, 2022
Cannabis Sciences
A Standard THC Unit: Standardizing Dosage in Cannabis Industry & Research
FEB 03, 2022
A Standard THC Unit: Standardizing Dosage in Cannabis Industry & Research
A primary limitation of cannabis research thus far has been the inconsistent quantification of exposure to the plant&rsq ...
FEB 24, 2022
Cannabis Sciences
Study Reveals Cannabis and Tobacco Affect the Lungs Differently
FEB 24, 2022
Study Reveals Cannabis and Tobacco Affect the Lungs Differently
Scientists recently discovered differences in how long-term consumption of cannabis and tobacco affect the lungs. A stud ...
MAR 02, 2022
Cannabis Sciences
How Science is Protecting Cannabis Consumers from Harmful Chemicals
MAR 02, 2022
How Science is Protecting Cannabis Consumers from Harmful Chemicals
The legalization of cannabis also comes with many tight laws and regulations to protect the consumers. This is done with ...
MAR 12, 2022
Cannabis Sciences
The Role of Cannabinoid Receptors
MAR 12, 2022
The Role of Cannabinoid Receptors
A recent review of research on cannabinoid receptors and their influence on signaling pathways provides insights into ho ...
Loading Comments...